Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
Interest Income Expense
Rosetta Genomics Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Interest Income Expense
-$31k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Interest Income Expense
$503k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Interest Income Expense
-$655k
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Interest Income Expense
-$12.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Interest Income Expense
$31k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Interest Income Expense
₪1.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
See Also
What is Rosetta Genomics Ltd's Interest Income Expense?
Interest Income Expense
-31k
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Interest Income Expense amounts to -31k USD.
What is Rosetta Genomics Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
97%
Over the last year, the Interest Income Expense growth was 97%.